This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allgemeine Literatur
Breitenecker G, Lax S. Tumoren des Corpus uteri, in: Holzner JH et al. (ed.) Histologische Tumorklassifikation der Österreichischen Gesellschaft für Pathologie. Springer Verlag 1994
Gompel C, Silverberg St G. Pathology in Gynecology and Obstetrics. 4th edition. Chapter 4, The Corpus Uteri pp 163–284. J B Lippincott Company, Philadelphia, 1994
Scully RE (editor). Histological Typing of Female Genital Tract Tumours. WHO International Histological Classification of Tumours. 2nd edition, Springer Verlag 1994.
Silverberg St G, Kurman RJ. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Atlas of Tumor Pathology. AFIP Fascicle 3, 3rd edition. 1992
Wittekind CH, Wagner G. TNM Klassifikation maligner Tumoren. 5. Auflage 1997, Springer Verlag
Originalarbeiten
Antunes CMF, Stolley PD, Rosenshein NB etal. Endometrial cancer and estrogen use: Report of a large case-control study. N Engl J Med (1979), 300: 9
Breitenecker, G., Bartl, W., Endler Margit, Gring, H.: Die prognostische Bedeutung morphologischer Parameter bei Endometriumkarzinomen. Onkologie (1984), 7(4):222–235, 1984
Enomoto T, Fujita M, Inoue M etal. Alterations in the p 53 tumor suppressor gene and ist association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res (1993), 53(8): 1883–1888
Gal D, Recio FO, Zamurovic D et al. Lymphvascular space involvement: A prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol (1991), 42: 142–145
Gleeson NC, Gonsalves R, Bonnar J. Plasminogen activator inhibitors in endometrial adenocarcinoma. Cancer (1993), 72(5): 1670–1672
Ikeda M, Watanabe Y, Nanjoh T et al. Evaluation of DNA ploidie in endometrial cancer. Gynecol Oncol (1993), 50 (1): 25–29
Kohler MF, Berchuck A, Davidoff AM et al. Overexpression and mutation of p 53 in endometrial carcinoma. Cancer Res (1992), 52 (6): 1622–1627
Koshiyama M, Konishi I, Wang DP et al. Immunohistochemical analysis of p 53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A (1993), 423(4): 265–271
Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer (1982), 49: 2547
Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: A long-term study of “untreated” hyperplasia in 170 patients. Cancer (1985), 56: 403
Lax SF, Piza ES, Ronnett BM, Kurman RJ. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki67, estrogen and progesterone receptor expression. Hum Pathol 1998, in press
Lynch HT, Krush AJ, Larsen AL, Magnuson CW. Endometrial carcinoma: Multiple primary malignancies, constitional factors and heredity. Am J Med Sci (1966), 252: 381
Lynch HT, Krush AJ, Thomas RJ, Lynch J. Cancer family syndrome. in: Lynch HT ed. Cancer genetics. Springfield III: Charles C Thomas (1976), 355–388
Magriples U, Naftolin F, Shwartz PE, Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breats cancer patients. J Clin Oncol (1993), 11(3): 485–490
Parazzina F, La Vecchia C, Bocciolone L, Francheschi S. Review: The epidemiology of endometrial cancer. Gynecol Oncol (1991), 41: 1
Sherman ME, Bittermann P, Rosenschein NB, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathological features. Am J Surg Pathol (1992), 16: 600–610
Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol (1995), 26: 1268–1274
Sidawy MK, Silverberg SG. Endometrial Carcinoma: Pathological factors of therapeutic and prognostic significance. Pathol Annu (1992), 27 (Part 2): 153–186
Tornos C, Siva EG, el-Naggar A et al. Aggressive stage I grade 1 endometrial carcinoma. Cancer (1992), 70 (4): 790–798
Uziely B, Lewin A, Brufman G et al. The effect of tamoxifen on the endometrium. Brest Cancer Res Treat (1993), 26(1): 101–105
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Sevelda, P., Lax, S.F., Breitenecker, G., Lukas, P. (1999). Korpuskarzinom. In: Smola, M.G. (eds) Manual der Chirurgischen Krebstherapie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6427-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6427-3_8
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82989-9
Online ISBN: 978-3-7091-6427-3
eBook Packages: Springer Book Archive